MacroGenics | Netto Inntekt



Net Income Endring Dato
AbbVie USD -22000000 1.58B 2024-12
Amgen USD 627M 2.2B 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Daiichi Sankyo JPY 61.93B 635M 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Genmab DKK 3.84B 2.58B 2024-12
Geron USD -25352000 1.1M 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
J&J USD 11B 7.57B 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 3.74B 586M 2024-12
Pfizer USD 410M 4.06B 2024-12
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Xencor USD -53479000 8.34M 2024-12



MacroGenics Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.